The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls

Atherosclerosis

Volumn 183, Issue 2, 2005, Pages 336-341

  Gouni Berthold, Ioanna ^a   Giannakidou, Eleni ^a   Faust, Michael ^a   Berthold, Heiner K ^b   Krone, Wilhelm ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Drug Commission of the German Medical Association   (Germany)

Author keywords

Atherosclerotic disease; Polymorphism; PPAR

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENOTYPE; GERMANY; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYPERTENSION; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PPAR DELTA; TRIGLYCERIDES;

EID: 27644501387     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.03.016     Document Type: Article

References (21)

1. H. Lim, R.A. Gupta, W.G. Ma, B.C. Paria, D.E. Moller, and J.D. Morrow Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta Genes Dev 13 1999 1561 1574
2. S. Kersten, B. Desvergne, and W. Wahli Roles of PPARs in health and disease Nature 405 2000 421 424
3. H.D. Shin, B.L. Park, and L.H. kim Genetic polymorphisms in peroxisome proliferator-activated receptor delta associated with obesity Diabetes 53 2004 847 851
4. J. Skogsberg, K. Kannisto, and L. Roshani Characterization of the human peroxisome proliferator activated receptor delta gene and its expression Int J Mol Med 6 2000 73 81
5. A. Schmidt, N. Endo, and S.J. Rutledge Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids Mol Endocrinol 6 1992 1634 1641
6. M.D. Leibowitz, C. Fievet, and N. Hennuyer Activation of PPARdelta alters lipid metabolism in db/db mice FEBS Lett 473 2000 333 336
7. W.R. Oliver, J.L. Shenk, and M.R. Snaith A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport Proc Natl Acad Sci USA 98 2001 5306 5311
8. Y.X. Wang, C.H. Lee, and S. Tiep Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity Cell 113 2003 159 170
9. H. Vosper, L. Patel, and T.L. Graham The peroxisome proliferator- activated receptor delta promotes lipid accumulation in human macrophages J Biol Chem 276 2001 44258 44265
10. W.R. Oliver, J.L. Shenk, and M.R. Snaith A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport Proc Natl Acad Sci USA 98 2001 5306 5311
11. J. Skogsberg, A.D. McMahon, and F. Karpe Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men J Intern Med 254 2003 597 604
12. J. Skogsberg, K. Kannisto, and T.N. Cassel Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men Arterioscler Thromb Vasc Biol 23 2003 637 643
13. I. Gouni-Berthold, E. Giannakidou, and D. Müller-Wieland Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls Am Heart J 147 2004 1117 1124
14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus ADA. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998; 22 (Suppl. 1):S5-S19.
15. A. Meirhaeghe, L. Fajas, and F. Gouilleux A functional polymorphism in a STAT5B site of the human PPARgamma3 gene promoter affects height and lipid metabolism in a French population Arterioscler Thromb Vasc Biol 23 2003 289 294
16. D.M. Flavell, I. Pineda Torra, and Y. Jamshidi Variation in the PPARa gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects Diabetologia 43 2000 673 680
17. M.C. Vohl, P. Lepage, and D. Gaudet Molecular scanning of the human PPARa gene: association of the L162V mutation with hyperapobetalipoproteinemia J Lipid Res 41 2000 945 952
18. H.K. Tabor, N.J. Risch, and R.M. Myers Candidate-gene approaches for studying complex genetic traits: practical considerations Nature Rev Gen 3 2002 391 397
19. L.R. Cardon, and L.J. Palmer Population stratification and spurious allelic associations Lancet 361 2003 598 604
20. H.M. Colhoun, P.M. McKeigue, and G. DaveySmith Problems of reporting genetic associations with complex outcomes Lancet 361 2003 598 604
21. J.P.A. Ioannidis, T.A. Trikalinos, E.E. Ntzani, and D.G. Contopoulos-Ioannidis Genetic associations in large versus small studies: an empirical assessment Lancet 361 2003 567 571